Development and evaluation of anthrax vaccine powder formulations for nasal mucosal delivery.

被引：0
|
作者：
Jiang, G
Sullivan, V
Mikszta, J
Joshi, S
Middaugh, CR
Huang, J
Alarcon, J
Ferriter, M
Woodley, W
Ford, B
Mar, K
Roy, C
Ulrich, R
Harvey, N
机构：
[1] BD Technol, Dept Adv Drug Delivery, Res Triangle Pk, NC 27709 USA
[2] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
182-BIOL
引用
收藏
页码：U201 / U201
页数：1
相关论文
共 50 条
  • [41] Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
    Debnath, Sujit Kumar
    Saisivam, Srinivasan
    Debanth, Monalisha
    Omri, Abdelwahab
    PLOS ONE, 2018, 13 (01):
  • [42] A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats
    Huang, J
    Garmise, RJ
    Crowder, TM
    Mar, K
    Hwang, CR
    Hickey, AJ
    Mikszta, JA
    Sullivan, VJ
    VACCINE, 2004, 23 (06) : 794 - 801
  • [43] N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery.: Development and characterization of minitablet and granule formulations
    van der Merwe, SM
    Verhoef, JC
    Kotzé, AF
    Junginger, HE
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (01) : 85 - 91
  • [44] Development of ciprofloxacin-loaded poly(vinyl alcohol) dry powder formulations for lung delivery
    Silva, Dina M.
    Paleco, Roberto
    Traini, Daniela
    Sencadas, Vitor
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 547 (1-2) : 114 - 121
  • [45] Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine
    YAN HuiMin
    Science China(Life Sciences), 2013, 56 (05) : 406 - 413
  • [46] Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine
    HuiMin Yan
    Science China Life Sciences, 2013, 56 : 406 - 413
  • [47] Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine
    YAN HuiMin
    Science China(Life Sciences), 2013, (05) : 406 - 413
  • [48] Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine
    Yan HuiMin
    SCIENCE CHINA-LIFE SCIENCES, 2013, 56 (05) : 406 - 413
  • [49] Optimization of formulation and device design for carrier-based nasal powder of influenza vaccine to maximize the delivery capability to the target site in the nasal cavity
    Mieda, Shiuhei
    Inoue, Kazuhiro
    Ito, Atsutoshi
    Yada, Shuichi
    Miyajima, Makoto
    Fukami, Toshiro
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2025, 104
  • [50] Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity
    Bakke, H
    Samdal, HH
    Holst, J
    Oftung, F
    Haugen, IL
    Kristoffersen, AC
    Haugan, A
    Janakova, L
    Korsvold, GE
    Krogh, G
    Andersen, EAS
    Djupesland, P
    Holand, T
    Rappuoli, R
    Haneberg, B
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2006, 63 (03) : 223 - 231
12345